Diaceutics (LON:DXRX) Issues Earnings Results

Diaceutics (LON:DXRX) released its earnings results on Tuesday. The company reported GBX 11 earnings per share for the quarter, Digital Look Earnings reports. Diaceutics had a negative return on equity of 3.94% and a negative net margin of 4.42%.The business had revenue of GBX 3,844 million for the quarter.

Diaceutics Stock Down 9.7%

DXRX stock opened at GBX 148.92 on Tuesday. Diaceutics has a twelve month low of GBX 112.25 and a twelve month high of GBX 180. The company has a market cap of £126.03 million, a PE ratio of -82.73 and a beta of 0.92. The business’s 50-day simple moving average is GBX 161.20 and its 200 day simple moving average is GBX 154.52. The company has a quick ratio of 9.92, a current ratio of 3.96 and a debt-to-equity ratio of 3.05.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.